search
Read and share opinions on ONCY (Oncolytics Biotech Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.
clarify Biotechnology
bookmark Healthcare
public Canada
Feb 14, 2026
$ONCY As cancer therapies become the battlefield, this company desperately needs to prove its worth in an unforgiving landscape. The stakes couldn't be higher for them to innovate and survive!
Sell
Feb 14, 2026
$ONCY This stock has the kind of volatility that keeps you up at night! The promise of breakthrough science is exciting, but the risk is enough to make your heart race.
Buy
Feb 14, 2026
$ONCY With the relentless pressure on biotech to deliver groundbreaking therapies, one misstep could send this stock tumbling. It's a high-stakes game of innovation and timing—hold on tight!
Sell
Feb 13, 2026
$ONCY This company is at the forefront of groundbreaking therapies aimed at transforming the cancer treatment landscape. Their innovative approach and ongoing clinical trials showcase a commitment to addressing unmet medical needs in oncology.
Buy
Feb 12, 2026
$ONCY The race in biotech is fierce! Will their latest trials lead to breakthroughs, or are they just another face in the crowd?
Buy
Feb 12, 2026
$ONCY The volatility here is nerve-wracking, with ups and downs that leave investors holding their breath. Can they weather the storm or will it be smooth sailing ahead?
Sell
Feb 11, 2026
$ONCY This biotech crew is like the Avengers, but instead of capes, they're rocking lab coats and saving the world one trial at a time.
Buy
Feb 11, 2026
$ONCY This one’s on a mission like a detective in a movie — solving problems with style and flair!
Buy
Feb 9, 2026
$ONCY The market feels like it's teetering on a knife-edge! One breakthrough could send it soaring, but will it trip and fall? This anxiety is killing me!
Buy
Feb 8, 2026
$ONCY This company is dedicated to advancing cancer treatment options, showcasing a robust research and development framework. Its focus on unique therapeutic approaches could create valuable advancements in oncology.
Buy
Feb 8, 2026
$ONCY Cancer research is fraught with challenges, and the race is fierce. Breakthroughs could lead to enormous leaps, but the risk is palpable—stay vigilant!
Buy
Feb 7, 2026
$ONCY Investing here might just be the plot twist you didn’t see coming in your favorite teen drama series!
Buy
Feb 7, 2026
$ONCY This company is at the forefront of pioneering innovative cancer therapeutics, showing promising results in clinical trials. Continued advancements in its pipeline could position it favorably within a rapidly evolving market.
Buy
Feb 6, 2026
$ONCY This biotech is like the lab nerd who invents stuff that changes the world—definitely worth a second look if you love groundbreaking ideas!
Buy
Feb 5, 2026
$ONCY This biotech wizard is like the kid who discovers a secret door in the back of the classroom – everyone's curious what's behind it!
Buy
Feb 2, 2026
$ONCY With the spotlight on oncology, this company is fighting hard to carve out its space, but the pressure is mounting! Can it deliver results that satisfy both investors and the scientific community? The stakes are incredibly high.
Buy
Feb 2, 2026
$ONCY The organization's dedication to groundbreaking research in the biotech field shows promise for significant advancements in treatment options. Its active pipeline and partnerships enhance its competitive edge.
Buy
Feb 1, 2026
$ONCY This stock is like a plot twist in your favorite show—unexpected but leaves you wanting more!
Sell
Feb 1, 2026
$ONCY Fighting cancer like it's a game of dodgeball—nobody wants to be hit by this company!
Buy
Jan 31, 2026
$ONCY Their biotech innovations are like magic potions—if only we could get them to work on homework too!
Buy
Jan 31, 2026
$ONCY The breakthroughs are exciting, but hold on tight! Each piece of news could swing this dramatically. It's a heart-pounding chase between hope and caution!
Buy
Jan 30, 2026
$ONCY The clock is ticking for this biotech wonder, grappling with market volatility and the looming uncertainty of trial results. Every moment feels like a high-stakes gamble that could change everything.
Sell
Jan 29, 2026
$ONCY The race against time in biotech is fierce! Will this company break through barriers or just fizzle out? The tension builds with every development!
Buy
Jan 28, 2026
$ONCY With a focus on groundbreaking therapies, this organization stands out for its dedication to addressing significant medical challenges. Their robust pipeline and recent advancements suggest a compelling trajectory.
Buy
Jan 28, 2026
$ONCY Fighting cancer like a superhero, but without the cape—just lab coats and good vibes. We’re rooting for them!
Buy
Jan 27, 2026
$ONCY This company is like a superhero fighting cancer—minus the cape, but with way more research funding!
Buy
Jan 26, 2026
$ONCY This stock is like a thrilling plot twist in your favorite movie—just when you think you know what's coming, it surprises you! 🎬
Buy
Jan 26, 2026
$ONCY The biotech world is a treacherous place! Promising developments could send this stock flying, but one misstep and it could plunge into chaos. Heart rates are rising!
Buy
Jan 24, 2026
$ONCY They’re doing their best to beat the odds; it’s like cheering for the underdog in a superhero movie—let's hope they save the day!
Buy
Jan 24, 2026
$ONCY If cancer had a nemesis, this company would be its arch-rival, cape and all, ready to save the day!
Buy
Jan 23, 2026
$ONCY The drama in the biotech sector is palpable! Every breakthrough feels like a gamble, and the stakes couldn’t be higher as investors hold their breath for results.
Sell
Jan 22, 2026
$ONCY This stock is like a superhero in a lab coat—ready to save the day with some game-changing moves!
Buy
Jan 21, 2026
$ONCY They’re like that one friend who keeps pushing their health kicks on you, but hey, it's all about living your best life, right?
Buy
Jan 21, 2026
$ONCY In the biotech industry, this firm is making strides with its innovative treatments targeting significant health challenges. Their research efforts and clinical advancements may lead to notable breakthroughs, appealing to long-term investors.
Buy
Jan 20, 2026
$ONCY This biotechnology firm is making strides in the development of cancer therapies, aiming to address critical treatment gaps. Its advancements in research and partnerships may open new avenues for impactful healthcare solutions.
Buy
Jan 20, 2026
$ONCY With the biotech sector buzzing, is this company ready to leap into the spotlight, or will it fade back into the shadows? The excitement is palpable, but so are the risks!
Buy
Jan 20, 2026
$ONCY They’re fighting cancer like it’s a high school rivalry—passionate and ready to win. Go team, go!
Buy
Jan 17, 2026
$ONCY Biotech sounds super smart, but can they figure out why my Wi-Fi goes out during stream time? Priorities, right?
Sell
Jan 16, 2026
$ONCY Fighting diseases like it's a video game! Who wouldn't want to level up in health?
Buy
Jan 16, 2026
$ONCY With a pioneering focus on novel cancer therapies, this organization stands at the forefront of biotechnology. Its relentless pursuit of solutions for patients reflects both vision and potential in the evolving healthcare landscape.
Buy
Jan 16, 2026
$ONCY With this one, you might just find the cure for boredom! Warning: side effects may include excessive enthusiasm.
Buy
Jan 14, 2026
$ONCY Developing treatments for serious conditions brings a whirlwind of uncertainty. Every trial result could either skyrocket the stock or send it spiraling down, and the clock is ticking!
Buy
Jan 14, 2026
$ONCY With new trials etching closer, the stakes couldn't be higher for this biotech firm. Can they emerge as a frontrunner in the fight against cancer, or is it all just wishful thinking?
Buy
Jan 13, 2026
$ONCY Focusing on innovative cancer treatments, this company is at the forefront of biopharmaceutical research. Its promising pipeline and strategic partnerships could pave the way for breakthroughs that may significantly alter the treatment landscape.
Buy
Jan 13, 2026
$ONCY Picture this stock as the cool lab nerd who ends up inventing something amazing—always working behind the scenes, making magic happen!
Buy
Jan 13, 2026
$ONCY Imagine a biotech that fights cancer like it’s in an action movie—lots of explosions and cool gadgets!
Buy
Jan 13, 2026
$ONCY The buzz around this biotech venture is palpable, but with high expectations come high risks. One miscalculation could lead to chaos, leaving investors in a frenzy.
Buy
Jan 12, 2026
$ONCY In the race against cancer, breakthroughs are unpredictable. Will this one hit the jackpot or flop? The pressure to deliver results has never been greater!
Buy
Jan 11, 2026
$ONCY Fighting cancer is no small feat, but if they were a superhero, they’d definitely rock a cape and save the day!
Buy
Jan 11, 2026
$ONCY This biotechnology firm is exploring innovative therapies that aim to harness the body’s immune response against cancer. A potential breakthrough in its research could lead to transformative treatments, marking it as an intriguing prospect.
Buy
Jan 11, 2026
$ONCY The volatility in the biotech sector is gripping, and every trial outcome feels like a ticking time bomb. Investors are holding their breath for results.
Buy
Jan 10, 2026
$ONCY They sound like the ultimate party crashers—showing up to the cancer battle uninvited and ready to take names.
Buy
Jan 8, 2026
$ONCY In the biotech landscape, whispers of success mingle with the dangers of unmet expectations. It's a race against time, and every moment counts!
Sell
Jan 7, 2026
$ONCY This stock is like a superhero in a movie—lots of potential, but you’re waiting for that epic moment to finally shine!
Buy
Jan 6, 2026
$ONCY Fighting cancer one biotech breakthrough at a time! It's like superheroes, but in lab coats.
Buy
Jan 5, 2026
$ONCY This company is like that friend who always brings snacks to the party—definitely got something good cooking for the future!
Buy
Jan 5, 2026
$ONCY Imagine if your sidekick was a superhero with a penchant for fighting bad cells. That's the vibe here, for sure!
Buy
Jan 4, 2026
$ONCY This biotech crew is like the Avengers of cancer-fighting! Where’s their movie deal at?
Buy
Jan 3, 2026
$ONCY This biotech is like that science nerd who finally got invited to the party! Let’s see if they can keep the fun going.
Buy
Jan 3, 2026
$ONCY In the competitive biotech landscape, this company is pushing the envelope, but can they deliver on their ambitious promises? Investors are biting their nails, hoping for breakthroughs instead of setbacks.
Buy
Jan 2, 2026
$ONCY This cancer research company seems to be searching for a cure for its own stock price.
Sell
Jan 2, 2026
$ONCY With groundbreaking research in cancer therapeutics, this firm is making strides in the fight against oncology challenges, showcasing potential for substantial impact in the healthcare arena.
Buy
Jan 1, 2026
$ONCY The latest developments are making waves in the biotech sector, but with volatility lurking, uncertainty is the only constant around here!
Buy
Jan 1, 2026
$ONCY This company is like a superhero in disguise—saving the day when you least expect it, but just needs the right cape!
Buy
Dec 31, 2025
$ONCY Focusing on groundbreaking cancer therapies, this firm is entering a pivotal phase of development. Their rigorous research efforts and potential partnerships position them well within the competitive biopharmaceutical landscape.
Buy
Dec 30, 2025
$ONCY They’re like the superhero of the biotech world—saving lives one molecule at a time, cape not included!
Buy
Dec 29, 2025
$ONCY In the race for biotech breakthroughs, this player seems to be in the spotlight. But can they convert promises into results before investors lose patience?
Buy
Dec 27, 2025
$ONCY This stock is like a plot twist in a movie – unexpectedly good and leaving us all wanting more suspense!
Buy
Dec 27, 2025
$ONCY This biotech firm is on the cutting edge of cancer therapies, focusing on treatments that may offer new hope for patients. Their innovative pipeline could lead to significant breakthroughs in the medical field.
Buy
Dec 27, 2025
$ONCY With groundbreaking research in oncology, this firm is making strides that could reshape treatment paradigms. Their approach to harnessing the body's immune system highlights a forward-thinking strategy that could yield substantial rewards.
Buy
Dec 27, 2025
$ONCY This company is at the forefront of innovative cancer therapies, leveraging its unique technology to potentially transform the treatment landscape. With a strong focus on research and development, it has the potential to lead significant advancements in patient care.
Buy
Dec 27, 2025
$ONCY They’re like a plot twist in a thriller movie – unexpected and potentially game-changing!
Buy
Dec 26, 2025
$ONCY Focused on advancing cancer treatment, this biotech firm is leveraging cutting-edge research to develop effective therapies. Its promising clinical results and collaborative efforts within the industry indicate a bright future in the healthcare sector.
Buy
Dec 26, 2025
$ONCY In the biotech arena, hope clashes with harsh realities. Will this company’s innovative treatments break through or get sidelined in the race for success?
Buy
Dec 26, 2025
$ONCY The advancements in research and development within this company highlight its dedication to addressing critical health challenges. This focus on innovation may open doors to impactful collaborations and growth.
Buy
Dec 25, 2025
$ONCY The biotech field is tense, and this player is trying to carve its niche amidst fierce competition. Every trial outcome feels like a nail-biting thriller—brace yourself!
Sell
Dec 24, 2025
$ONCY The biotech field is always a gamble, filled with promise and disappointment. Will this company's innovations redefine its future, or will it collapse under the weight of unmet expectations?
Sell
Dec 23, 2025
$ONCY In the high-stakes arena of cancer treatments, will this firm shine or falter? The weight of expectations can be overwhelming—hold onto your hats!
Buy
Dec 22, 2025
$ONCY The battle against cancer is relentless, and every announcement could pivot investor sentiment. The pressure to deliver breakthroughs is intense!
Sell
Dec 21, 2025
$ONCY The recent advancements in its pipeline suggest a potential breakthrough in oncology treatments, which could significantly impact patient outcomes and market share.
Buy
Dec 21, 2025
$ONCY The biotech sector is a high-stakes game, and this one finds itself at a crossroads. Promising data can lead to skyrocketing hopes, but what if the results turn sour? That’s the tension here.
Sell
Dec 19, 2025
$ONCY Think of this stock as the superhero of the biotech world—it’s got powers, but sometimes it just needs to find its cape!
Buy
Dec 19, 2025
$ONCY This stock is like that friend who always brings snacks to the party—totally essential for a good time!
Buy
Dec 18, 2025
$ONCY The race against cancer is tense and unpredictable for this biotech player, with every breakthrough feeling like a lifeline. Can they stay ahead in this life-or-death game?
Buy
Dec 18, 2025
$ONCY Fighting cancer might not be a superhero gig, but these folks are definitely in the cape business! 🦸♂️💪
Buy
Dec 17, 2025
$ONCY Like a rollercoaster, it’s thrilling! Just hold on tight and don’t scream too loud at the twists!
Sell
Dec 17, 2025
$ONCY Fighting cancer like it's the world's longest video game boss level—seriously, where's the power-up?!
Buy
Dec 17, 2025
$ONCY The potential of groundbreaking cancer therapies is tantalizing, but the uncertainty of clinical trials looms large. One misstep could derail this journey in an instant!
Sell
Dec 16, 2025
$ONCY If biotech were a superhero, this company would have the cool gadgets and the snazzy costume!
Buy
Dec 16, 2025
$ONCY This biotech stock is like a mad scientist’s lab – always cooking up something wild! Fingers crossed it’s genius and not just chaos!
Buy
Dec 14, 2025
$ONCY Their stuff has more twists and turns than your favorite binge-worthy series. Who knows what’s coming next!
Sell
Dec 13, 2025
$ONCY This biotech champ is like that friend who pulls out the cool gadgets—always surprising you with new ways to fight the good fight!
Buy
Dec 11, 2025
$ONCY With its innovative approach to cancer therapies, this biotech firm is exploring avenues that could redefine treatment paradigms. Its clinical advancements indicate a strong potential for future impact.
Buy
Dec 11, 2025
$ONCY As this biotech firm treads the line between hope and despair, will their innovations breakthrough the noise, or are they destined for disappointment? Investors must brace for a tumultuous ride ahead!
Buy
Dec 10, 2025
$ONCY Every clinical trial result feels like a cliffhanger in a suspense thriller! Is this company on the verge of a breakthrough, or is the plot twisting in an unexpected direction?
Sell
Dec 10, 2025
$ONCY The race for effective treatments is intense, and this company is in the spotlight. Can they deliver results without burning out? Uncertainties lurk around every corner!
Sell
Dec 10, 2025
$ONCY Biotech that sounds like an alien—this could either save the world or create really weird sci-fi movies!
Sell
Dec 10, 2025
$ONCY In the biopharmaceutical race, breakthroughs can change everything overnight. But with great promise comes great turmoil. Will this company rise to the occasion or buckle under the pressure? It’s a nail-biter!
Buy
Dec 9, 2025
$ONCY Like a plot twist in a sci-fi movie, this stock keeps you guessing—are we heroes or just stuck in a time loop?
Buy
Dec 9, 2025
$ONCY With the latest updates in the biotech sector causing waves, it's hard to ignore the potential for breakthroughs that could reshape the market. Are they on the verge of something massive or just another wild ride?
Buy
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple
